'Dancing Molecules' Treatment Receives FDA Orphan Drug Designation - News Center
"Dancing molecules," the promising new treatment for acute spinal cord injuries developed at Northwestern University, has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA).